Early Discharge Pathway Registry

Sponsor
Queen Mary University of London
Study ID
NCT06040528
Status
Recruiting
Apply to this trial

Conditions

  • Myocardial Infarction
  • Non-ST Elevation Myocardial Infarction
  • ST Elevation Myocardial Infarction

Eligibility Criteria

Sex
ALL
Age
16 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading causes of mortality worldwide. With advances in technology and our understanding of cardiac disease, we can now treat CAD using minimally invasive interventional techniques. This has revolutionised treatment for and improved the lives of many patients with CAD. Although trials have assessed various therapeutic strategies in various populations, real-world evidence of intervention and medical treatment among patients with CAD is increasingly recognised as an important part of providing safety and efficacy data and improving the care we provide. Regional heart attack services have improved clinical outcomes following ST-segment elevation myocardial infarction (STEMI) by facilitating early reperfusion by primary percutaneous coronary intervention (PCI). Early discharge after primary PCI is welcomed by patients and increases the efficiency of health care. This data will add to that literature by assessing the characteristics and outcomes of patients with CAD, concentrating on those who are discharged via the early discharge pathway. It will also identify and characterise predictors of outcomes, and improve risk stratification and diagnostic evaluation.

Key Dates

First listed
Sep 15, 2023
Start date
Nov 11, 2023
Status verified
Feb 2026
Primary completion
Oct 30, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
20,000 participants (estimated)

Arms

  • Arm: Patients discharged on the Early Discharge Pathway at Barts Heart Centre
    This study aims to assess, in a real-world setting, the safety, efficacy and feasibility of further investigations in patients with acute coronary syndrome who are admitted to Barts Heart Centre and are discharged via the early discharge pathway.

Primary Outcome Measure

Assessment of Titration of medication [ Time Frame: 1 year ]

Central Contacts

Related Studies